Skip to main content
SpringerLink
Log in

Markers of activation of coagulation and fibrinolysis in patients with Cushing’s syndrome

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Patients with active Cushing’s syndrome have an increased thrombotic tendency. We chose to reassess the mechanism underlying the thrombophilic state associated with this clinical condition using sensitive markers of coagulation and fibrinolysis activation in 17 patients with active disease. The results were compared with those obtained in 12 Cushing’s patients successfully treated by surgery and in 20 normal individuals. The general pattern of results in patients with active disease was the finding of increased levels of von Willebrand factor (VWF: Ag), a marker of enhanced metabolic function of endothelial cells (VWF:Ag 181±42 vs 110±43, p<0.001 in normal subjects), accompanied by signs of heightened thrombin and plasmin generation, expressed by high levels of thrombin-antithrombin (TAT 5.59±3.6 vs 3.06±0.92 ng/ml in controls, p<0.01) and plasmin-antiplasmin complexes (PAP 407±176 vs 245±67 ng/ml in controls, p<0.01). VWF:Ag and TAT values were significantly higher in hypertensive than in normotensive patients with active disease (205±40 vs 155±26 U/dl, p<0.05 and 7.49±3.7 vs 3.45±1.8, p<0.01, respectively). Plasma levels of plasminogen activator inhibitor type 1 were higher, though not to a statistically significant extent, in patients with active disease compared to controls (12.8±12.3 vs 5.6±7.4 IU/ml, NS) and positively correlated with body mass index (r=0.66, p<0.01). After surgical control of Cushing’s syndrome, there was a partial or complete reversal of the abnormalities to values similar to those found in normal individuals. Our data suggest that the thrombophilic state present in patients with active Cushing’s syndrome is related to an enhanced metabolic function of endothelial cells; this in turn may be caused by an heightened production of thrombin with secondary hyperfibrinolysis. Primary prophylaxis with anticoagulants is recommended in these patients when they are exposed to a thrombophilic condition such as surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Pezzulich R.A., Mannix H. Immediate complications of adrenal surgery. Ann. Surg. 1970, 172: 125–130.

    CAS  PubMed Central  PubMed  Google Scholar 

  2. Blichert-Toft M., Bargerskov A., Lockwood K., Hasner E. Operative treatment, surgical approach and related complication in 195 operations upon the adrenal glands. Surg. Gynecol. Obstet. 1972, 135: 261–266.

    CAS  PubMed  Google Scholar 

  3. Sjoberg H.E., Blombäck M., Granberg P.O. Thromboembolic complications, heparin treatment and increase in coagulation factors in Cushing’s syndrome. Acta Med. Scand. 1976, 199: 95–98.

    Article  CAS  PubMed  Google Scholar 

  4. La Brocca A., Terzolo M., Pia A., Paccotti P., De Giuli P., Angeli A. Recurrent thromboembolism as a hallmark of Cushing’s syndrome. J. Endocrinol. Invest. 1997, 20: 211–214.

    PubMed  Google Scholar 

  5. Diez J.J., Iglesias P. Pulmonary thromboembolism after inferior petrosal sinus sampling in Cushing’s syndrome. Clin. Endocrinol. 1997, 46: 775–777.

    Google Scholar 

  6. Mizokami T., Okamura K., Sato K., Kuroda T., Sadoshima S., Fujishima M. Risk factors for brain infarction in patients with Cushing’s disease. Case reports. Angiology 1996, 47: 1011–1017.

    Article  CAS  PubMed  Google Scholar 

  7. Jackson J.A., Trowbridge A., Smigiel M. Fatal pulmonary thromboembolism after successful transsphenoidal hypophysectomy for Cushing’s disease. South Med. J. 1990, 83: 960–996.

    Article  CAS  PubMed  Google Scholar 

  8. Nichols R. Concurrent illness and complications associated with canine hyperadrenocorticism. Probl. Vet. Med. 1990, 2: 565–572.

    CAS  PubMed  Google Scholar 

  9. Isacson S. Effect of prednisolone on the coagulation and fibrinolytic system. Scand. J. Haematol. 1970, 7: 212–221.

    Article  CAS  PubMed  Google Scholar 

  10. Dal Bo Zanon R., Fornasiero L., Boscaro M., Cappellato G., Fabris F., Girolami A. Increased factor VIII associated activities in Cushing’s syndrome: a probable hypercoagulable state. Thromb. Haemost. 1982, 47: 116–117.

    Google Scholar 

  11. Dal Bo Zanon R., Fornasiero L., Boscaro M., Ruffato G., Luzzato G., Fabris F., Girolami A. Clotting changes in Cushing’s syndrome: elevated factor VIII activity. Folia Haematologica 1983, 110: 268–277.

    Google Scholar 

  12. Ikkala E., Myllyla G., Pelkonen R., Rasi V., Viinikka L., Yliokorkala O. Haemostatic parameters in Cushing’s syndrome. Acta Med. Scand. 1985, 217: 507–511.

    Article  CAS  PubMed  Google Scholar 

  13. Patrassi G.M., Dal Bo Zanon R., Boscaro M., Martinelli S., Girolami A. Further studies on the hypercoagulable state of patients with Cushing’s syndrome. Thromb. Haemost. 1985, 54: 518–520.

    CAS  PubMed  Google Scholar 

  14. Casonato A., Pontara E., Boscaro M., Sonino N., Sartorello F., Ferasin S., Girolami A. Abnormalities of von Willebrand factor are also part of the prothrombotic state of Cushing’s syndrome. Blood Coag. Fibrinol. 1999, 10: 145–151.

    Article  CAS  Google Scholar 

  15. Uddhammar A., Rantapaa-Dahlovist S., Nilsson T.K. Plasminogen activator inhibitor and von Willebrand factor in polymyalgia rheumatica. Clin. Rheumatol. 1992, 11: 211–215.

    Article  CAS  PubMed  Google Scholar 

  16. Patrassi G.M., Sartori M.T., Viero M.L., Scarano L., Boscaro M., Girolami A. The fibrinolytic potential in patients with Cushing’s disease: a clue to their hypercoagulable state. Blood Coag. Fibrinol. 1992, 3: 789–793.

    Article  CAS  Google Scholar 

  17. Huges A., McVerry B.A., Wilkinson L., Goldstone A.H., Lewis D., Bloom A. Diabetes, a hypercoagulable state? Haemostatic variables in newly diagnosed type 2 diabetic patients. Acta Haematol. 1983, 69: 254–259.

    Article  Google Scholar 

  18. Boneu B., Durand D., Connillon F., Charlet J.P., Bierme R., Sue G.M. Increased level in factor VIII complex in severe arterial hypertension. Haemostasis 1978, 7: 332–338.

    CAS  PubMed  Google Scholar 

  19. Oikarinen A., Hoythya M., Jarvinen M. Dexamethasone-induced plasminogen activator inhibitor: characterization, purification and preparation of monoclonal anti-bodies. Arch. Dermatol. Res. 1990, 282: 153–158.

    Article  CAS  PubMed  Google Scholar 

  20. Laug W.E. Glucocorticoids inhibit plasminogen activator production by endothelial cells. Thromb. Haemost. 1983, 50: 888–892.

    CAS  PubMed  Google Scholar 

  21. Barouski-Miller P.A., Gelehrter T.D. Paradoxical effects of glucocorticoids on regulation of plasminogen activator activity of rat hepatoma cells. Cell. Biol. 1982, 79: 2319–232.

    CAS  Google Scholar 

  22. Merlini P.A., Bauer K., Mannucci P.M. Laboratory detection of the prethrombotic state. In: Verstraete M., Fuster V., Topol E. J. (Eds.), Cardiovascular Thrombosis. Lippincott-Raven Publisher, Philadelphia, 1998, p. 103.

    Google Scholar 

  23. Invitti C., Pecori Giraldi F., De Martin M., Cavagnini F., Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis. Diagnosis and management of Cushing’s syndrome: results of an Italian multicentre study. J. Clin. Endocrinol. Metab. 1999, 84: 440–448.

    CAS  PubMed  Google Scholar 

  24. Mannucci P.M., Coppola R. Von Willebrand factor. In: Jespersen J., Bertina R.M., Haverkate F. (Eds.), ECAT Assay Procedures. A Manual of Laboratory Techniques. Kluwer Academic Publisher, Lancaster (UK), 1992, p. 71.

    Chapter  Google Scholar 

  25. Coppola R., Tombesi S., Valentini F., Albertini A., Mannucci P.M. Enzyme linked immunosorbent assay of human factor VII based upon a monoclonal antibody that recognizes the native conformation of the protein. Thromb. Res. 1992, 68: 283–293.

    Article  CAS  PubMed  Google Scholar 

  26. Widgoose P., Nemerson Y., Hansen L.L., Nielsen F.E., Glazer S., Hender U. Measurement of basal levels of factor VIIa in haemophilia A and B patients. Blood 1992, 80: 25–28.

    Google Scholar 

  27. Invitti C., De Martin M., Delitala G., Veldhuis J.D., Cavagnini F. Altered morning and nighttime pulsatile ACTH and cortisol release in polycystic ovary syndrome. Metabolism 1998, 47: 143–148.

    Article  CAS  PubMed  Google Scholar 

  28. Mannucci P.M. Von Willebrand factor: a marker of endothelial damage? Arterioscler. Thromb. Vasc. Biol. 1998, 18: 1359–1362.

    Article  CAS  PubMed  Google Scholar 

  29. Blann A.C., Nagvi T., Waite M., McCollum C.N. Von Willebrand factor and endothelial damage in essential hypertension. J. Hum. Hypertens. 1993, 7: 107–111.

    CAS  PubMed  Google Scholar 

  30. Pedrinelli R., Giampietro O., Carmassi F., Melillo E., Dell’Omo G., Catapano G., Matteucci E., Talarco L., Morale M., De Negri F., Di Bello V. Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet 1994, 344: 14–18.

    Article  CAS  PubMed  Google Scholar 

  31. Lundgren C.H., Brown S.L., Nordt T.K., Sobel B.E., Fujii S. Elaboration of type-1 plasminogen activator inhibitor from adipocytes: A potential pathogenetic link between obesity and cardiovascular disease. Circulation 1996, 93: 106–110.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Istituto Auxologico Italiano, University of Milan Istituto Scientifico Ospedale San Luca, IRCCS, Via Spagnoletto 3, 20149, Milano, Italy

    L. M. Fatti (2nd Chair of Endocrinology), C. Invitti (2nd Chair of Endocrinology) &  Francesco Cavagnini (2nd Chair of Endocrinology)

  2. Angelo Bianchi Bonomi Hemophilia and Thrombosis Center and Institute of Internal Medicine IRCCS Maggiore Hospital, University of Milan, Italy

    B. Bottasso, R. Coppola & P. M. Mannucci

Authors
  1. L. M. Fatti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Bottasso
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Invitti
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. Coppola
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Francesco Cavagnini
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. P. M. Mannucci
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Francesco Cavagnini.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fatti, L.M., Bottasso, B., Invitti, C. et al. Markers of activation of coagulation and fibrinolysis in patients with Cushing’s syndrome. J Endocrinol Invest 23, 145–150 (2000). https://doi.org/10.1007/BF03343697

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03343697

Key-words

Search

Navigation